Investigator Databank Set To Reduce Time And Cost Of Clinical Trials

By Ed Miseta, Chief Editor, Clinical Leader

Bringing together five large pharmaceutical companies for any endeavor can be a challenge. However, the potential for creating a common golden record of 50,000 sites, over 7,300 protocols, and 180,000 investigators, will definitely get their attention. The Investigator Databank has been able to do just that.

Via the Investigator Databank, five major pharmaceutical companies (Janssen, Lilly, Merck, Pfizer, and Novartis) have agreed to share their investigator information with each other. DrugDev, a family of technology solutions that bring together investigators, sponsors, and CROs, is the hosting partner for the Investigator Databank.